Adverse events · adults with cystic fibrosis
1 finding from 1 review
FEV1 · adults with cystic fibrosis
1 finding from 1 review
Time to next exacerbation · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction or preference · adults with cystic fibrosis
1 finding from 1 review
Behavioural outcome: medication use Multimodal/complexk, ATCS Plus versus usual care or enhanced usual care (plus information) · adolescents with asthma
1 finding from 1 review
Requirement for additional medication · women with primary dysmenorrhoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Requirement for additional medication · women with primary dysmenorrhoea
Combined OCP may leads to lower requirement for additional medication compared with placebo or no treatment (low certainty).
1 finding from 1 review
Requirement for additional medication · women with primary dysmenorrhoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Residents with at least one psychotropic medication · older people in all long‐term care settings
1 finding from 1 review
Residents with at least one psychotropic medication ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Residents with at least one psychotropic medication · older people in all long‐term care settings
Summary of findings table ‐ Organisational intervention showed no clear difference in residents with at least one psychotropic medication compared with usual care (moderate certainty).
1 finding from 1 review
Proportion of participants with IOP ≤ 21 mmHg, with or without ocular hypotensive medications, 4 to 6 weeks · people with neovascular glaucoma
Anti‐VEGF may leads to higher proportion of participants with IOP ≤ 21 mmHg, with or without… compared with no anti‐VEGF (low certainty).
1 finding from 1 review
Medication appropriateness · older people receiving polypharmacy
1 finding from 1 review
The number of potentially inappropriate medications (PIMs) · older people receiving polypharmacy
1 finding from 1 review
The proportion of patients with one or more potentially inappropriate medication (PIM) · older people receiving polypharmacy
It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potentially… compared with usual care (very low certainty).
1 finding from 1 review
Irritability · participants (any age) with a clinical diagnosis of ASD who have displayed one or more unwanted or challenging behaviours at baseline…
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health literacy – Medication understanding Multiple measures used: Demonstration by means of correct dosage in dosing tray (0 to 5) Correct interpretation of label contents, 11 labels MUQ (score · migrants
1 finding from 1 review
Medication adherence (continuous) · migrants
1 finding from 1 review
Proportion of participants requiring further IOP‐lowering interventions (additional surgery, medications, or both) (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants requiring further IOP‐lowering… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review